Synopsis of recent research by authors named "Sella Provan"
- Sella Provan's recent research primarily focuses on the intersection of chronic inflammatory conditions, particularly rheumatological disorders, and the implications of immunosuppressive therapies, exploring treatment adherence, immune response to vaccinations, and disease activity monitoring across various patient populations.
- Provan's studies highlight critical findings such as the link between non-adherence to urate-lowering therapy in gout and adverse outcomes, as well as the effectiveness of secukinumab treatment for both radiographic and non-radiographic axial spondyloarthritis patients in real-world settings.
- The research also emphasizes the complexities of immune responses in patients undergoing treatments like TNF inhibitors and rituximab, shedding light on their vaccine responses and the development of therapeutic strategies tailored for individuals with immune-mediated inflammatory diseases.
